“We are pleased to assist Anavex, our first customer, in evaluating the potential of ANAVEX 2-73 and ANAVEX PLUS to increase CD69 expression using LymPro in blood derived from AD patients,” said Gerald E. Commissiong, President & CEO of Amarantus.

Why the use of the word "customer"? He is so full of BS!!!!!!! Oh wait... "customer" could mean anything. Has nothing to do with payment or exchange of money.

So the 10Q is out. Anyone have any thoughts? Any? Or are we, as I believe, screwed. I didn't see anything in the 10Q that gave me hope.